Sector: MedicalCardiome Pharma Corporation (NASDAQ: CRME)
Ranking History
Scan Date: | 11/10/2009 |
Sector: | Medical |
Funamental : | 2 |
Technical : | 276 |
Performance : | 235 |
Overall: | 196 |
Number of Stocks: | 306 |
Scan Date: | 11/3/2009 |
Sector: | Medical |
Funamental : | 2 |
Technical : | 253 |
Performance : | 272 |
Overall: | 204 |
Number of Stocks: | 306 |
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 1 |
Technical : | 188 |
Performance : | 233 |
Overall: | 140 |
Number of Stocks: | 306 |
Headlines
- TSX Review: Index Closes Lower
Nov 19, 2009 05:15 PM | AGU, CRME, MFC
- Stocks try to gain 3 in row
Nov 05, 2009 10:31 AM | BVF, COST, CRME, CVS, TWC, TWX
- Cardiome And Astellas Announce Initiation Of Patient Enrolment In ACT 5 Trial
Oct 28, 2009 04:58 PM | CRME
- Cardiome Pharma Corp. Announces Final Results of Tender Offer
Oct 16, 2009 08:55 PM | CRME
- TSX Review: Index Closed Higher
Oct 14, 2009 05:01 PM | AGU
- Cardiome Pharma Corp. Announces Preliminary Results of Tender Offer
Oct 14, 2009 06:01 AM | CRME
- Cardiome to Present at JMP Securities Healthcare Conference
Oct 02, 2009 01:31 PM | CRME
- Cardiome Announces Next Steps for GED-aPC Asset and Transition of Dr. Charles Fisher to Consulting Role
Sep 25, 2009 01:45 PM | CRME, MRK
- Akela Pharma announces new leadership
Sep 02, 2009 07:33 AM | CRME, GENZ
- Cardiome Announces Upcoming Presentation Of Results Of Phase 2b Clinical Trial Of Vernakalant (Oral) At The European Society Of Cardiology Congress 2009
Aug 28, 2009 01:30 PM | CRME
- Cardiome Reports Third Quarter Results
Nov 09, 2009 09:52 AM | CRME
- Cardiome to Release Third Quarter Results
Nov 06, 2009 06:51 PM | CRME
- Cardiome To Present At Oppenheimer Healthcare Conference
Nov 02, 2009 02:55 PM | CRME
- Cardiome Pharma Corp. Announces New Expiration Date For Tender Offer
Sep 25, 2009 05:54 PM | CRME
- Cardiome Announces Upcoming Presentation Of Results Of Phase 2b Clinical Trial Of Vernakalant (Oral) At The European Society Of Cardiology Congress 2009
Aug 28, 2009 01:53 PM | CRME
- Movers: Waste Management, ITW, Calpine
Aug 12, 2008 10:52 AM | ACMR, ALY, BRNC, CCO, CHIP, CIEN
- Cardiome Pharma Corp. Announces Commencement of US$27.5 Million Tender Offer
Sep 01, 2009 03:54 PM | CRME
- Cardiome Pharma Corp. Announces Tender Offer To Purchase Up To US$27.5 Million Of Its Common Shares
Aug 25, 2009 05:56 PM | CRME
- Cardiome Reports Second Quarter Results
Aug 11, 2009 07:56 AM | CRME
- Additional Clinical Trial to be Conducted for KYNAPID Under FDA Special Protocol Agreement
Aug 10, 2009 07:45 PM | CRME
- Cardiome to Hold Conference Call
Aug 10, 2009 04:52 PM | CRME
- Cardiome Announces Management Transition
Aug 03, 2009 05:16 PM | CRME
- Cardiome Achieves Milestone From Collaboration With Merck Co., Inc.
Jul 28, 2009 01:53 PM | CRME
- Cardiome Achieves Milestone From Collaboration With Merck Co., Inc.
Jul 28, 2009 12:35 PM | CRME
- Cardiome Achieves Milestone From Collaboration With Merck & Co., Inc.
Jul 28, 2009 11:45 AM | CRME
- Cardiome Announces That Collaboration and License Agreement with Merck & Co., Inc. Now Effective
May 19, 2009 08:31 AM | CRME
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
CRME
|
Compare to S&P
|
| YTD |
-13.41 %
|
-28.47 %
|
| 4 Weeks |
-9.43 %
|
-9.91 %
|
| 12 Weeks |
-6.41 %
|
-12.18 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 50.00 %
|
|
EPS Growth in Last Year: 94.12 %
|
|
Sales Growth in Last Quarter: 165.27 %
|
|
Sales Growth in Last Quarter: 3,977.75 %
|
|
